Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

266 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
EBCC-14 manifesto: Addressing disparities in access to innovation for patients with metastatic breast cancer across Europe.
Ignatiadis M, Poulakaki F, Spanic T, Brain E, Lacombe D, Sonke GS, Vincent-Salomon A, Van Duijnhoven F, Meattini I, Kaidar-Person O, Aftimos P, Lecouvet F, Cardoso F, Retèl VP, Cameron D. Ignatiadis M, et al. Among authors: van duijnhoven f. Eur J Cancer. 2024 Aug;207:114156. doi: 10.1016/j.ejca.2024.114156. Epub 2024 Jun 7. Eur J Cancer. 2024. PMID: 38861756 Free article. Review.
Identifying pathologic complete response of the breast after neoadjuvant systemic therapy with ultrasound guided biopsy to eventually omit surgery: Study design and feasibility of the MICRA trial (Minimally Invasive Complete Response Assessment).
van der Noordaa MEM, van Duijnhoven FH, Loo CE, van Werkhoven E, van de Vijver KK, Wiersma T, Winter-Warnars HAO, Sonke GS, Vrancken Peeters MTFD. van der Noordaa MEM, et al. Among authors: van duijnhoven fh, van de vijver kk, van werkhoven e. Breast. 2018 Aug;40:76-81. doi: 10.1016/j.breast.2018.04.015. Epub 2018 May 22. Breast. 2018. PMID: 29698928
The impact of an online patient decision aid for women with breast cancer considering immediate breast reconstruction: study protocol of a multicenter randomized controlled trial.
Ter Stege JA, Woerdeman LAE, Hahn DEE, van Huizum MA, van Duijnhoven FH, Kieffer JM, Retèl VP, Sherman KA, Witkamp AJ, Oldenburg HSA, Bleiker EMA. Ter Stege JA, et al. BMC Med Inform Decis Mak. 2019 Aug 19;19(1):165. doi: 10.1186/s12911-019-0873-1. BMC Med Inform Decis Mak. 2019. PMID: 31426772 Free PMC article. Clinical Trial.
Minimally Invasive Complete Response Assessment of the Breast After Neoadjuvant Systemic Therapy for Early Breast Cancer (MICRA trial): Interim Analysis of a Multicenter Observational Cohort Study.
van Loevezijn AA, van der Noordaa MEM, van Werkhoven ED, Loo CE, Winter-Warnars GAO, Wiersma T, van de Vijver KK, Groen EJ, Blanken-Peeters CFJM, Zonneveld BJGL, Sonke GS, van Duijnhoven FH, Vrancken Peeters MTFD. van Loevezijn AA, et al. Among authors: van duijnhoven fh, van de vijver kk, van der noordaa mem, van werkhoven ed. Ann Surg Oncol. 2021 Jun;28(6):3243-3253. doi: 10.1245/s10434-020-09273-0. Epub 2020 Dec 2. Ann Surg Oncol. 2021. PMID: 33263830 Free PMC article.
Pathologic response of ductal carcinoma in situ to neoadjuvant systemic treatment in HER2-positive breast cancer.
Groen EJ, van der Noordaa MEM, Schaapveld M, Sonke GS, Mann RM, van Ramshorst MS, Lips EH, Vrancken Peeters MTFD, van Duijnhoven FH, Wesseling J. Groen EJ, et al. Among authors: van duijnhoven fh, van der noordaa mem, van ramshorst ms. Breast Cancer Res Treat. 2021 Aug;189(1):213-224. doi: 10.1007/s10549-021-06235-2. Epub 2021 May 4. Breast Cancer Res Treat. 2021. PMID: 33945043 Free PMC article.
Toward omitting sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with clinically node-negative breast cancer.
van der Noordaa MEM, van Duijnhoven FH, Cuijpers FNE, van Werkhoven E, Wiersma TG, Elkhuizen PHM, Winter-Warnars G, Dezentje V, Sonke GS, Groen EJ, Stokkel M, Vrancken Peeters MTFD. van der Noordaa MEM, et al. Among authors: van duijnhoven fh, van werkhoven e. Br J Surg. 2021 Jun 22;108(6):667-674. doi: 10.1002/bjs.12026. Br J Surg. 2021. PMID: 34157085
Preferences of Treatment Strategies among Women with Low-Risk DCIS and Oncologists.
Byng D, Retèl VP, Engelhardt EG, Groothuis-Oudshoorn CGM, van Til JA, Schmitz RSJM, van Duijnhoven F, Wesseling J, Bleiker E, van Harten WH, On Behalf Of The Grand Challenge Precision Consortium. Byng D, et al. Among authors: van til ja, van duijnhoven f, van harten wh. Cancers (Basel). 2021 Aug 6;13(16):3962. doi: 10.3390/cancers13163962. Cancers (Basel). 2021. PMID: 34439126 Free PMC article.
Three-year follow-up of de-escalated axillary treatment after neoadjuvant systemic therapy in clinically node-positive breast cancer: the MARI-protocol.
van Loevezijn AA, van der Noordaa MEM, Stokkel MPM, van Werkhoven ED, Groen EJ, Loo CE, Elkhuizen PHM, Sonke GS, Russell NS, van Duijnhoven FH, Vrancken Peeters MTFD. van Loevezijn AA, et al. Among authors: van duijnhoven fh, van der noordaa mem, van werkhoven ed. Breast Cancer Res Treat. 2022 May;193(1):37-48. doi: 10.1007/s10549-022-06545-z. Epub 2022 Mar 3. Breast Cancer Res Treat. 2022. PMID: 35239072 Free PMC article.
266 results